Vertex Pharmaceuticals Unearned Premium on Insurance Contract (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

470.57 +9.43 (+2.04%) USD | NASDAQ | Jan 22, 12:59

View Unearned Premium on Insurance Contract (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	--
Amgen, Inc.	--
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Alnylam Pharmaceuticals, Inc.	--